The Evolution of BioSense: Lessons Learned and Future Directions
The Evolution of BioSense: Lessons Learned and Future Directions
复制标题
DOI：
10.1177/0033354917706954
复制
发表时间：
2017-07-01
影响因子：
3.3
通讯作者：
Yoon, Paula W.
中科院分区：
文献类型：
--
作者：
Gould, Deborah W.;Walker, David;Yoon, Paula W.
2003年启动了生物感方案，目的是建立一个全国性的综合公共卫生监测系统，以便及早发现和评估与生物恐怖主义有关的潜在疾病。多年来，该计划已经从最初的疾病控制和预防中心为中心的计划，以一个专注于在州和地方一级建立症状监测能力。症状监测的使用也从早期的重点关注与生物恐怖主义有关的疾病警报，发展到对各种危险事件和疾病爆发的情况了解和反应。BioSense的未来发展（现在的国家综合征监测计划）包括，在短期内，重点关注数据质量，强调稳定性，一致性和可靠性，从长期来看，增加容量和创新，新的数据源和系统功能，以及探索新兴技术和分析。
The BioSense program was launched in 2003 with the aim of establishing a nationwide integrated public health surveillance system for early detection and assessment of potential bioterrorism-related illness. The program has matured over the years from an initial Centers for Disease Control and Prevention-centric program to one focused on building syndromic surveillance capacity at the state and local level. The uses of syndromic surveillance have also evolved from an early focus on alerts for bioterrorism-related illness to situational awareness and response, to various hazardous events and disease outbreaks. Future development of BioSense (now the National Syndromic Surveillance Program) includes, in the short term, a focus on data quality with an emphasis on stability, consistency, and reliability and, in the long term, increased capacity and innovation, new data sources and system functionality, and exploration of emerging technologies and analytics.